BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19946126)

  • 1. Treatment of fibroadenomatosis in 14 cats with aglepristone - changes in blood parameters and follow-up.
    Jurka P; Max A
    Vet Rec; 2009 Nov; 165(22):657-60. PubMed ID: 19946126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fibroadenomatous hyperplasia in cats with aglépristone.
    Görlinger S; Kooistra HS; van den Broek A; Okkens AC
    J Vet Intern Med; 2002; 16(6):710-3. PubMed ID: 12465769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist.
    Wehrend A; Hospes R; Gruber AD
    Vet Rec; 2001 Mar; 148(11):346-7. PubMed ID: 11316295
    [No Abstract]   [Full Text] [Related]  

  • 4. What is your diagnosis? Feline mammary fibroepithelial hyperplasia.
    Sontas BH; Turna O; Ucmak M; Ekici H
    J Small Anim Pract; 2008 Oct; 49(10):545-7. PubMed ID: 18844825
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the anti-progestin aglepristone on the uterine tissue of cats administered medroxyprogesterone acetate.
    Muphung W; Rungsipipat A; Chatdarong K
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():204-7. PubMed ID: 19754569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in the cat with the progesterone antagonist Aglépristone (Alizine)].
    Meisl D; Hubler M; Arnold S
    Schweiz Arch Tierheilkd; 2003 Mar; 145(3):130-6. PubMed ID: 12677773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of bitches with pyometra, medically treated with aglepristone.
    Ros L; Holst BS; Hagman R
    Theriogenology; 2014 Dec; 82(9):1281-6. PubMed ID: 25234791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of abortion with aglepristone in cats on day 45 and 46 after mating.
    Georgiev P; Bostedt H; Goericke-Pesch S; Dimitrov M; Petkov P; Stojanthev K; Tsoneva V; Wehrend A
    Reprod Domest Anim; 2010 Oct; 45(5):e161-7. PubMed ID: 19961554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aglepristone: A review on its clinical use in animals.
    Gogny A; Fiéni F
    Theriogenology; 2016 Mar; 85(4):555-66. PubMed ID: 26525399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone.
    Nak D; Nak Y; Tuna B
    J Feline Med Surg; 2009 Jun; 11(6):499-502. PubMed ID: 19097817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas.
    Guil-Luna S; Millán Y; De Andres J; Rollón E; Domingo V; García-Macías J; Sánchez-Céspedes R; Martín de Las Mulas J
    Vet Comp Oncol; 2017 Jun; 15(2):391-399. PubMed ID: 26781329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of growth hormone excess in dogs with the progesterone receptor antagonist aglépristone.
    Bhatti SF; Duchateau L; Okkens AC; Van Ham LM; Mol JA; Kooistra HS
    Theriogenology; 2006 Sep; 66(4):797-803. PubMed ID: 16497368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma.
    Guil-Luna S; Stenvang J; Brünner N; De Andrés FJ; Rollón E; Domingo V; Sánchez-Céspedes R; Millán Y; Martín de Las Mulas J
    BMC Vet Res; 2014 Dec; 10():296. PubMed ID: 25515784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of parturition in the bitch with the progesterone-receptor blocker aglépristone.
    Baan M; Taverne MA; Kooistra HS; de Gier J; Dieleman SJ; Okkens AC
    Theriogenology; 2005 Apr; 63(7):1958-72. PubMed ID: 15823352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal puppy survival after planned caesarean section in the bitch using aglepristone as a primer: A retrospective study on 74 cases.
    Roos J; Maenhoudt C; Zilberstein L; Mir F; Borges P; Furthner E; Niewiadomska Z; Nudelmann N; Fontbonne A
    Reprod Domest Anim; 2018 Nov; 53 Suppl 3():85-95. PubMed ID: 30474341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas.
    Guil-Luna S; Sánchez-Céspedes R; Millán Y; De Andrés FJ; Rollón E; Domingo V; Guscetti F; Martín de Las Mulas J
    J Vet Intern Med; 2011; 25(3):518-23. PubMed ID: 21488964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of ovariohysterectomy on feline mammary fibroepithelial hyperplasia treatment.
    de Melo EH; Câmara DR; Notomi MK; Jabour FF; Garrido RA; Nogueira AC; Júnior JC; de Souza FW
    J Feline Med Surg; 2021 Apr; 23(4):351-356. PubMed ID: 32812465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of pregnancy in cats using aglepristone on days 5 and 6 after mating.
    Goericke-Pesch S; Georgiev P; Wehrend A
    Theriogenology; 2010 Jul; 74(2):304-10. PubMed ID: 20451994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the progesterone receptor antagonist aglepristone on implantation administered on days 6 and 7 after mating in rabbits.
    Ozalp GR; Calişkan C; Seyrek-Intaş K; Wehrend A
    Reprod Domest Anim; 2010 Jun; 45(3):505-8. PubMed ID: 19019074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aglepristone, a progesterone receptor antagonist, in a dog with a vaginal fibroma.
    Rollón E; Millán Y; de las Mulas JM
    J Small Anim Pract; 2008 Jan; 49(1):41-3. PubMed ID: 17784929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.